ANDA 208632, held by Amneal Pharms Co. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 208632 (Clomipramine Hydrochloride), held by Amneal Pharms Co, was first approved by FDA on Oct 31, 2018, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 2018 | Original application | Approved | None posted |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| May 2, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 1, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 31, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters